Voomi Supply | $10,000,000 | (Mar 10, 2026)
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
Certified by Founder
Lodge
Exeliom Biosciences
start up
France
- Dijon, Bourgogne-Franche-Comté
- 21/07/2023
- Series A
- $8,898,320
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
- Industry Pharmaceutical Manufacturing
- Website https://www.exeliombio.com/
- LinkedIn https://www.linkedin.com/company/nextbiotix/
Related People
Benjamin HadidaFounder
France -
Paris, Île-de-France
Biotech company builder and new therapeutic class explorer
Crafting | $5,500,000 | (Mar 10, 2026)
Cylake | $45,000,000 | (Mar 10, 2026)
Augur | $15,000,000 | (Mar 10, 2026)
DiligenceSquared (YC F25) | $5,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
Dify | $30,000,000 | (Mar 10, 2026)
Mega | $11,500,000 | (Mar 10, 2026)
Denki (YC F25) | $4,100,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)